Picture loading failed.

Anti-ITGA2B_ITGB3 therapeutic antibody (Pre-made Tadocizumab biosimilar,Fab) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Tadocizumab is a humanized monoclonal antibody that acts on the cardiovascular system. It binds to integrin αIIbβ3, a fibrinogen and fibronectin receptor found on platelets.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-542-1mg 1mg 3090
GMP-Bios-ab-542-10mg 10mg 21890
GMP-Bios-ab-542-100mg 100mg 148000
GMP-Bios-ab-542-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-ITGA2B_ITGB3 therapeutic antibody (Pre-made Tadocizumab biosimilar,Fab)
INN Name Tadocizumab
TargetITGA2B_ITGB3
FormatFab
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2005
Year Recommended2006
CompaniesPDL BioPharma;Yamanouchi
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedCoronary artery restenosis;Stroke;Thrombosis
Development Techna